Etiology of pneumonia in a pediatric population with high pneumococcal vaccine coverage: A prospective study

Pediatric Infectious Disease Journal

Volumn 35, Issue 3, 2016, Pages e69-e75

  Berg, Are Stuwitz ^a   Inchley, Christopher Stephen ^a   Aase, Audun ^b   Fjaerli, Hans Olav ^a   Bull, Reidun ^a   Aaberge, Ingeborg ^b   Leegaard, Truls Michael ^a,c   Nakstad, Britt ^a,c  

^a AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Bacterial pneumonia; Etiology; Pneumococcal Vaccines; Viral pneumonia

Indexed keywords

PNEUMOCOCCUS VACCINE;

ADULT; ARTICLE; BACTERIUM CULTURE; BLOOD; HOSPITAL PATIENT; HUMAN; HUMAN RESPIRATORY SYNCYTIAL VIRUS; MAJOR CLINICAL STUDY; MYCOPLASMA; MYCOPLASMOSIS; OBSERVATIONAL STUDY; OUTPATIENT; PLEURA; PNEUMONIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; STREPTOCOCCUS PNEUMONIAE; ADOLESCENT; CHILD; DIAGNOSTIC IMAGING; FEMALE; HEALTH SURVEY; IMMUNOLOGY; INFANT; MALE; NORWAY; PRESCHOOL CHILD; VACCINATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; NORWAY; PNEUMOCOCCAL VACCINES; PNEUMONIA; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; VACCINATION;

EID: 84959184621     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000001009     Document Type: Article

References (46)

1. Harris M, Clark J, Coote N, et al. British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. Thorax. 2011;66 (Suppl 2):111-23.
2. Bradley JS, Byington CL, Shah SS, et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis. 2011;53:e25-e76.
3. Clark JE. Determining the microbiological cause of a chest infection. Arch Dis Child. 2015;100:193-197.
4. Elemraid MA, Sails AD, Eltringham GJ, et al; North East of England Paediatric Respiratory Infection Study Group. Aetiology of paediatric pneumonia after the introduction of pneumococcal conjugate vaccine. Eur Respir J. 2013;42:1595-1603.
5. Angoulvant F, Levy C, Grimprel E, et al. Early impact of 13-valent pneumococcal conjugate vaccine on community-acquired pneumonia in children. Clin Infect Dis. 2014;58:918-924.
6. Ruuskanen O, Lahti E, Jennings LC, et al. Viral pneumonia. Lancet. 2011;377:1264-1275.
7. Jain S, Williams DJ, Arnold SR, et al. Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med. 2015;372:835-845.
8. Michelow IC, Olsen K, Lozano J, et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics. 2004;113:701-707.
9. Trogstad L, Ung G, Hagerup-Jenssen M, et al. The Norwegian immunisation register-SYSVAK. Euro Surveill. 2012;17.
10. Cherian T, Mulholland EK, Carlin JB, et al. Standardized interpretation of paediatric chest radiographs for the diagnosis of pneumonia in epidemiological studies. Bull World Health Organ. 2005;83:353-359.
11. Hurlen P, Borthne A, Dahl FA, et al. Does PACS improve diagnostic accuracy in chest radiograph interpretations in clinical practice? Eur J Radiol. 2012;81:173-177.
12. Tunsjo HS, Berg AS, Inchley CS, et al. Comparison of nasopharyngeal aspirate with flocked swab for PCR-detection of respiratory viruses in children. APMIS. 2015;123:473-477.
13. Kanclerski K, Blomquist S, Granström M, et al. Serum antibodies to pneumolysin in patients with pneumonia. J Clin Microbiol. 1988;26:96-100.
14. Claesson BA, Trollfors B, Brolin I, et al. Etiology of community-acquired pneumonia in children based on antibody responses to bacterial and viral antigens. Pediatr Infect Dis J. 1989;8:856-862.
15. Kolberg J, Aase A, Naess LM, et al. Human antibody responses to pneumococcal surface protein A and capsular polysaccharides during acute and convalescent stages of invasive disease in adult patients. Pathog Dis. 2014;70:40-50.
16. Strachan RE, Cornelius A, Gilbert GL, et al; Australian Research Network in Empyema (ARNiE). A bedside assay to detect Streptococcus pneumoniae in children with empyema. Pediatr Pulmonol. 2011;46:179-183.
17. Hamer DH, Egas J, Estrella B, et al. Assessment of the Binax NOW Streptococcus pneumoniae urinary antigen test in children with nasopharyngeal pneumococcal carriage. Clin Infect Dis. 2002;34:1025-1028.
18. Dowell SF, Garman RL, Liu G, et al. Evaluation of Binax NOW, an assay for the detection of pneumococcal antigen in urine samples, performed among pediatric patients. Clin Infect Dis. 2001;32:824-825.
19. Drummond P, Clark J, Wheeler J, et al. Community acquired pneumonia-a prospective UK study. Arch Dis Child. 2000;83:408-412.
20. Heiskanen-Kosma T, Korppi M, Jokinen C, et al. Etiology of childhood pneumonia: serologic results of a prospective, population-based study. Pediatr Infect Dis J. 1998;17:986-991.
21. Don M, Fasoli L, Paldanius M, et al. Aetiology of community-acquired pneumonia: serological results of a paediatric survey. Scand J Infect Dis. 2005;37:806-812.
22. Tsolia MN, Psarras S, Bossios A, et al. Etiology of community-acquired pneumonia in hospitalized school-age children: evidence for high prevalence of viral infections. Clin Infect Dis. 2004;39:681-686.
23. Juvén T, Mertsola J, Waris M, et al. Etiology of community-acquired pneumonia in 254 hospitalized children. Pediatr Infect Dis J. 2000;19:293-298.
24. Cevey-Macherel M, Galetto-Lacour A, Gervaix A, et al. Etiology of community-acquired pneumonia in hospitalized children based on WHO clinical guidelines. Eur J Pediatr. 2009;168:1429-1436.
25. Wubbel L, Muniz L, Ahmed A, et al. Etiology and treatment of community-acquired pneumonia in ambulatory children. Pediatr Infect Dis J. 1999;18:98-104.
26. Hamano-Hasegawa K, Morozumi M, Nakayama E, et al; Acute Respiratory Diseases Study Group. Comprehensive detection of causative pathogens using real-time PCR to diagnose pediatric community-acquired pneumonia. J Infect Chemother. 2008;14:424-432.
27. Shah SS, Dugan MH, Bell LM, et al. Blood cultures in the emergency department evaluation of childhood pneumonia. Pediatr Infect Dis J. 2011;30:475-479.
28. McCulloh RJ, Koster MP, Yin DE, et al. Evaluating the use of blood cultures in the management of children hospitalized for community-acquired pneumonia. PLoS One. 2015;10:e0117462.
29. Blystad H, Anestad G, Vestrheim DF, et al. Increased incidence of Mycoplasma pneumoniae infection in Norway 2011. Euro Surveill. 2012;17.
30. Esposito S, Daleno C, Prunotto G, et al. Impact of viral infections in children with community-acquired pneumonia: results of a study of 17 respiratory viruses. Influenza Other Respir Viruses. 2013;7:18-26.
31. Cilla G, Oñate E, Perez-Yarza EG, et al. Viruses in community-acquired pneumonia in children aged less than 3 years old: High rate of viral coinfection. J Med Virol. 2008;80:1843-1849.
32. Christensen A, Døllner H, Skanke LH, et al. Detection of spliced mRNA from human bocavirus 1 in clinical samples from children with respiratory tract infections. Emerg Infect Dis. 2013;19:574-580.
33. Gardiner SJ, Gavranich JB, Chang AB. Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children. Cochrane Database Syst Rev. 2015;1:CD004875.
34. Vuori-Holopainen E, Salo E, Saxén H, et al. Etiological diagnosis of childhood pneumonia by use of transthoracic needle aspiration and modern microbiological methods. Clin Infect Dis. 2002;34:583-590.
35. Murdoch DR, O'Brien KL, Driscoll AJ, et al. Laboratory methods for determining pneumonia etiology in children. Clin Infect Dis. 2012;54 (Suppl 2):S146-S152.
36. Lahti E, Peltola V, Waris M, et al. Induced sputum in the diagnosis of childhood community-acquired pneumonia. Thorax. 2009;64:252-257.
37. Korppi M, Leinonen M, Ruuskanen O. Pneumococcal serology in children's respiratory infections. Eur J Clin Microbiol Infect Dis. 2008;27:167-175.
38. Tuerlinckx D, Smet J, De Schutter I, et al. Evaluation of a WHO-validated serotype-specific serological assay for the diagnosis of pneumococcal etiology in children with community-acquired pneumonia. Pediatr Infect Dis J. 2013;32:e277-e284.
39. De Schutter I, Vergison A, Tuerlinckx D, et al. Pneumococcal aetiology and serotype distribution in paediatric community-acquired pneumonia. PLoS One. 2014;9:e89013.
40. Jartti T, Jartti L, Peltola V, et al. Identification of respiratory viruses in asymptomatic subjects: asymptomatic respiratory viral infections. Pediatr Infect Dis J. 2008;27:1103-1107.
41. Resti M, Moriondo M, Cortimiglia M, et al; Italian Group for the Study of Invasive Pneumococcal Disease. Community-acquired bacteremic pneumococcal pneumonia in children: diagnosis and serotyping by real-time polymerase chain reaction using blood samples. Clin Infect Dis. 2010;51:1042-1049.
42. Nascimento-Carvalho CM, Ribeiro CT, Cardoso MR, et al. The role of respiratory viral infections among children hospitalized for community-acquired pneumonia in a developing country. Pediatr Infect Dis J. 2008;27:939-941.
43. Avni T, Mansur N, Leibovici L, et al. PCR using blood for diagnosis of invasive pneumococcal disease: systematic review and meta-analysis. J Clin Microbiol. 2010;48:489-496.
44. Vestrheim DF, Løvoll O, Aaberge IS, et al. Effectiveness of a 2 + 1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway. Vaccine. 2008;26: 3277-3281.
45. van Deursen AM, van Mens SP, Sanders EA, et al; Invasive Pneumococcal Disease Sentinel Surveillance Laboratory Group. Invasive pneumococcal disease and 7-valent pneumococcal conjugate vaccine, the Netherlands. Emerg Infect Dis. 2012;18:1729-1737.
46. Black S, Shinefield H, Fireman B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J. 2000;19:187-195.